QQQ   311.83 (+0.48%)
AAPL   160.26 (+0.62%)
MSFT   277.81 (+1.47%)
META   203.92 (+0.87%)
GOOGL   105.72 (+0.76%)
AMZN   100.49 (-0.12%)
TSLA   197.24 (-0.17%)
NVDA   271.12 (+3.48%)
NIO   9.35 (+0.86%)
BABA   84.90 (+1.43%)
AMD   97.82 (+1.97%)
T   18.57 (+0.16%)
F   11.82 (+0.85%)
MU   58.73 (+0.17%)
CGC   1.96 (-0.40%)
GE   92.10 (-0.09%)
DIS   96.19 (-0.36%)
AMC   4.56 (+3.40%)
PFE   40.37 (-0.71%)
PYPL   75.71 (-1.32%)
NFLX   300.85 (-1.62%)
QQQ   311.83 (+0.48%)
AAPL   160.26 (+0.62%)
MSFT   277.81 (+1.47%)
META   203.92 (+0.87%)
GOOGL   105.72 (+0.76%)
AMZN   100.49 (-0.12%)
TSLA   197.24 (-0.17%)
NVDA   271.12 (+3.48%)
NIO   9.35 (+0.86%)
BABA   84.90 (+1.43%)
AMD   97.82 (+1.97%)
T   18.57 (+0.16%)
F   11.82 (+0.85%)
MU   58.73 (+0.17%)
CGC   1.96 (-0.40%)
GE   92.10 (-0.09%)
DIS   96.19 (-0.36%)
AMC   4.56 (+3.40%)
PFE   40.37 (-0.71%)
PYPL   75.71 (-1.32%)
NFLX   300.85 (-1.62%)
QQQ   311.83 (+0.48%)
AAPL   160.26 (+0.62%)
MSFT   277.81 (+1.47%)
META   203.92 (+0.87%)
GOOGL   105.72 (+0.76%)
AMZN   100.49 (-0.12%)
TSLA   197.24 (-0.17%)
NVDA   271.12 (+3.48%)
NIO   9.35 (+0.86%)
BABA   84.90 (+1.43%)
AMD   97.82 (+1.97%)
T   18.57 (+0.16%)
F   11.82 (+0.85%)
MU   58.73 (+0.17%)
CGC   1.96 (-0.40%)
GE   92.10 (-0.09%)
DIS   96.19 (-0.36%)
AMC   4.56 (+3.40%)
PFE   40.37 (-0.71%)
PYPL   75.71 (-1.32%)
NFLX   300.85 (-1.62%)
QQQ   311.83 (+0.48%)
AAPL   160.26 (+0.62%)
MSFT   277.81 (+1.47%)
META   203.92 (+0.87%)
GOOGL   105.72 (+0.76%)
AMZN   100.49 (-0.12%)
TSLA   197.24 (-0.17%)
NVDA   271.12 (+3.48%)
NIO   9.35 (+0.86%)
BABA   84.90 (+1.43%)
AMD   97.82 (+1.97%)
T   18.57 (+0.16%)
F   11.82 (+0.85%)
MU   58.73 (+0.17%)
CGC   1.96 (-0.40%)
GE   92.10 (-0.09%)
DIS   96.19 (-0.36%)
AMC   4.56 (+3.40%)
PFE   40.37 (-0.71%)
PYPL   75.71 (-1.32%)
NFLX   300.85 (-1.62%)
NASDAQ:VSTM

Verastem - VSTM Stock Forecast, Price & News

$0.42
-0.03 (-5.56%)
(As of 03/22/2023 12:00 PM ET)
Add
Compare
Today's Range
$0.43
$0.45
50-Day Range
$0.39
$0.71
52-Week Range
$0.29
$2.13
Volume
187,556 shs
Average Volume
798,646 shs
Market Capitalization
$85.29 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$4.25

Verastem MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
887.7% Upside
$4.25 Price Target
Short Interest
Healthy
0.58% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
-0.31mentions of Verastem in the last 14 days
Based on 8 Articles This Week
Insider Trading
Selling Shares
$8,900 Sold Last Quarter
Proj. Earnings Growth
N/A

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.01 out of 5 stars

Medical Sector

600th out of 983 stocks

Pharmaceutical Preparations Industry

291st out of 478 stocks


VSTM stock logo

About Verastem (NASDAQ:VSTM) Stock

Verastem, Inc. is a biopharmaceutical company, which engages in the development and commercialization of drugs for the treatment of cancer. The company was founded by Richard H. Aldrich, Michelle Dipp, Piyush Gupta, Satish Jindal, Eric S. Lander, Robert F. Weinberg, and Christoph H. Westphal on August 4, 2010 and is headquartered in Needham, MA.

Receive VSTM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Verastem and its competitors with MarketBeat's FREE daily newsletter.

VSTM Stock News Headlines

Verastem (NASDAQ:VSTM) Coverage Initiated at StockNews.com
My No. 1 dividend stock for a LIFETIME of income.
Few people realize this… But dividends account for up to 90% of the stock market's returns over the past century!  I think it's a crying shame folks don't know how powerful dividends are.
Verastem (NASDAQ:VSTM) Stock Rating Reaffirmed by HC Wainwright
Verastem (NASDAQ:VSTM) Now Covered by StockNews.com
My No. 1 dividend stock for a LIFETIME of income.
Few people realize this… But dividends account for up to 90% of the stock market's returns over the past century!  I think it's a crying shame folks don't know how powerful dividends are.
Verastem: Moving Forward (NASDAQ:VSTM) - Seeking Alpha
See More Headlines
Receive VSTM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Verastem and its competitors with MarketBeat's FREE daily newsletter.

VSTM Company Calendar

Last Earnings
11/04/2021
Today
3/22/2023
Next Earnings (Estimated)
5/08/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
Biotechnology
Sector
Medical
Current Symbol
NASDAQ:VSTM
CUSIP
92337C10
Fax
N/A
Employees
48
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$4.25
High Stock Price Forecast
$6.00
Low Stock Price Forecast
$3.00
Forecasted Upside/Downside
+823.9%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
5 Analysts

Profitability

Net Income
$-73,810,000.00
Pretax Margin
-2,843.30%

Debt

Sales & Book Value

Annual Sales
$2.60 million
Book Value
$0.23 per share

Miscellaneous

Free Float
194,256,000
Market Cap
$92.31 million
Optionable
Optionable
Beta
0.81

Key Executives

  • Brian M. StuglikBrian M. Stuglik
    Chief Executive Officer & Director
  • Dan PatersonDan Paterson
    President & Chief Operating Officer
  • Daniel Calkins
    VP, Chief Financial & Accounting Officer
  • Jonathan Pachter
    Chief Scientific Officer
  • Louis J. Denis
    Chief Medical Officer













VSTM Stock - Frequently Asked Questions

Should I buy or sell Verastem stock right now?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Verastem in the last twelve months. There are currently 5 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" VSTM shares.
View VSTM analyst ratings
or view top-rated stocks.

What is Verastem's stock price forecast for 2023?

5 Wall Street research analysts have issued 12 month price targets for Verastem's stock. Their VSTM share price forecasts range from $3.00 to $6.00. On average, they expect the company's stock price to reach $4.25 in the next twelve months. This suggests a possible upside of 844.4% from the stock's current price.
View analysts price targets for VSTM
or view top-rated stocks among Wall Street analysts.

How have VSTM shares performed in 2023?

Verastem's stock was trading at $0.4025 at the beginning of the year. Since then, VSTM shares have increased by 11.8% and is now trading at $0.45.
View the best growth stocks for 2023 here
.

When is Verastem's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, May 8th 2023.
View our VSTM earnings forecast
.

How were Verastem's earnings last quarter?

Verastem, Inc. (NASDAQ:VSTM) announced its earnings results on Thursday, November, 4th. The biopharmaceutical company reported ($0.13) earnings per share for the quarter, missing the consensus estimate of ($0.08) by $0.05.

What is Robert Forrester's approval rating as Verastem's CEO?

11 employees have rated Verastem Chief Executive Officer Robert Forrester on Glassdoor.com. Robert Forrester has an approval rating of 100% among the company's employees. This puts Robert Forrester in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Verastem own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Verastem investors own include TherapeuticsMD (TXMD), Micron Technology (MU), Novavax (NVAX), Inovio Pharmaceuticals (INO), Gilead Sciences (gild), Sorrento Therapeutics (SRNE), SCYNEXIS (SCYX), TG Therapeutics (TGTX), Amarin (AMRN) and Viking Therapeutics (VKTX).

What is Verastem's stock symbol?

Verastem trades on the NASDAQ under the ticker symbol "VSTM."

Who are Verastem's major shareholders?

Verastem's stock is owned by a variety of retail and institutional investors. Top institutional investors include Geode Capital Management LLC (0.87%), Jefferies Financial Group Inc. (0.78%), Millennium Management LLC (0.51%), Renaissance Technologies LLC (0.29%), Two Sigma Investments LP (0.26%) and Dimensional Fund Advisors LP (0.25%). Insiders that own company stock include Brian M Stuglik, Dan Paterson, Daniel Calkins, Ra Capital Management, LP, Robert E Gagnon and Timothy J Barberich.
View institutional ownership trends
.

How do I buy shares of Verastem?

Shares of VSTM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Verastem's stock price today?

One share of VSTM stock can currently be purchased for approximately $0.45.

How much money does Verastem make?

Verastem (NASDAQ:VSTM) has a market capitalization of $90.31 million and generates $2.60 million in revenue each year. The biopharmaceutical company earns $-73,810,000.00 in net income (profit) each year or ($0.38) on an earnings per share basis.

How can I contact Verastem?

Verastem's mailing address is 117 KENDRICK STREET SUITE 500, NEEDHAM MA, 02494. The official website for the company is www.verastem.com. The biopharmaceutical company can be reached via phone at (781) 292-4200 or via email at bsullivan@verastem.com.

This page (NASDAQ:VSTM) was last updated on 3/22/2023 by MarketBeat.com Staff